AF
BCAX

Allworth Financial’s Bicara Therapeutics BCAX Stock Holding History

Allworth Financial’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23K Buy
75
+1
+1% +$22 ﹤0.01% 4464
2026
Q1 		$1.47K Buy
74
+21
+40% +$361 ﹤0.01% 4452
2025
Q4 		$892 Buy
53
+11
+26% +$188 ﹤0.01% 4391
2025
Q3 		$664 Sell
42
-252
-86% -$2.82K ﹤0.01% 4366
2025
Q2 		$2.73K Sell
294
-31
-10% -$369 ﹤0.01% 3570
2025
Q1 		$5.08K Buy
+325
New +$4.32K ﹤0.01% 2750

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Allworth Financial's BCAX Position: Q2 2026 in Review

Allworth Financial increased its Bicara Therapeutics (BCAX) stake by 1.4% in Q2 2026, buying an estimated $22 and bringing the position to 75 shares worth $2.23K. The position accounts for ﹤0.01% of the portfolio, ranked #4464.

Allworth Financial first reported a position in BCAX in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.08K in Q1 2025. 172 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • Allworth Financial held 75 shares of Bicara Therapeutics worth $2.23K as of Q2 2026.
  • Allworth Financial bought 1 Bicara Therapeutics share in Q2 2026, an estimated $22.
  • Bicara Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4464 holding.
  • Allworth Financial first reported a position in Bicara Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Allworth Financial's Bicara Therapeutics position peaked at $5.08K in Q1 2025.
  • 172 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.